Aurobindo Pharma receives US FTC antitrust clearance for its Lannett Company acquisition, nearing deal closure by end...
pharma manufacturing
FTC mandates Aurobindo Pharma divest four drug products as a condition for its $250M acquisition of Lannett...
Maharashtra FDA mandates hospitals to let patients buy medicines from any licensed pharmacy, boosting consumer rights and...
India's drug regulator increases price caps for essential cancer drugs cisplatin and carboplatin by 50% to combat...
Britain's MHRA approves Novo Nordisk's oral weight-loss drug, making the UK the first European market for this...
AstraZeneca's Enhertu receives Indian regulatory approval for first-line HER2-positive breast cancer treatment, offering a new therapeutic option.
India's drug pricing authority is reviewing essential cancer drug prices, including carboplatin and cisplatin, due to escalating...
Serum Institute of India partners with Oxford University to produce a new Ebola vaccine, backed by $8.6M...
Novartis' experimental actinium-based drug shows promising anti-tumor activity in prostate cancer patients, with higher response rates in...
Cipla aims for 40-50 global product filings in three years, focusing on innovation, complex generics, and biosimilars...